• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Two Canadian nurses honoured for contributions to MS

June 19, 2024  

Geographic determinants of health: location, location

June 3, 2024  

New guidance on use of sNfL in practice

May 27, 2024  

Treatment initiation with a higher-efficacy DMT: update from AAN

April 25, 2024  

REPORT FROM AAN 2024 – THURSDAY, APRIL 18

April 18, 2024  

REPORT FROM AAN 2024 – WEDNESDAY, APRIL 17

April 17, 2024  

REPORT FROM AAN 2024 – TUESDAY, APRIL 16

April 16, 2024  

REPORT FROM AAN 2024 – MONDAY, APRIL 15

April 15, 2024  

Fluid biomarkers: theory and practice

March 18, 2024  

Evobrutinib in MS – ACTRIMS Forum update

March 11, 2024  
Previous
5
6
7
8
9
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • DMT prescribing in Canada – Part 2 posted on June 12, 2025
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions